M
LIVE

Serial Number

88064146

Owner

Medicago Inc.

Attorney

Michelle P. Ciotola

Filing Date

Aug 3, 2018

Add to watchlist:

No watchlists yet
View on USPTO

M Trademark

Serial Number: 88064146 • Registration: 6367149

M is a trademark filed by Medicago Inc. on August 3, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Medicago Inc.

suite 600
Québec (Québec) G1V3V9 , CA

Entity Type: 03

Trademark Details

Filing Date

August 3, 2018

Registration Date

June 1, 2021

Published for Opposition

March 16, 2021

Goods & Services

Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies

Wholesale store, retail store, and online retail store services featuring pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies

Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer

Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 1, 2026 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 4, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 4, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 4, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 4, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 4, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 4, 2023 COAR
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2021 CRFA
ASSIGNED TO LIE
Feb 2, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 22, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 21, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 21, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 21, 2020 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 21, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 21, 2020 GNSL
SUSPENSION LETTER WRITTEN
Feb 21, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 2020 CRFA
ASSIGNED TO LIE
Feb 14, 2020 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 11, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 5, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 5, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 5, 2019 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 5, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 5, 2019 GNSL
SUSPENSION LETTER WRITTEN
Mar 5, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 1, 2018 GNRN
NON-FINAL ACTION E-MAILED
Sep 1, 2018 GNRT
NON-FINAL ACTION WRITTEN
Sep 1, 2018 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2018 NWOS
NEW APPLICATION ENTERED
Aug 7, 2018 NWAP